FDA Approvals, Breakthrough Designations, Priority Reviews, and More

In case you missed any, check out our recap of the episodes of OncLive On Air that aired in June 2026.

PRAME-directed therapies represent a novel approach in the treatment of advanced melanoma.

The top 5 OncLive TV videos of the week cover insights in bladder cancer, chronic myeloid leukemia, multiple myeloma, pancreatic cancer, and chronic lymphocytic leukemia.

The FDA approved gedatolisib in PIK3CA wild-type breast cancer, granted full approval to selpercatinib in RET fusion+ tumors, and more.

A research team from Huntsman Cancer Institute at the University of Utah showed a pathway-targeted therapy that could be an effective melanoma treatment.

Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.

Experts shared the key data that stood out in hematologic oncology at the 2026 ASCO Annual Meeting.

Peter E. Fecci, MD, PhD, discusses unmet needs in glioblastoma management and the early promise of CAR T-cell therapy in this disease.